INS and metabolic syndrome: Moreover, in obese nondiabetic adults with metabolic syndrome, even higher doses of CrPic (1000 μg day−1 for 16 weeks) did not improve insulin sensitivity, serum lipids, or other cardiometabolic risk markers [99].